Do you want to read an article? Please log in or register.
Use of RAAS inhibitors and risk of clinical deterioration in COVID-19: results from an Italian cohort of 133 hypertensives
Hypertension
Related content
RECOMMENDED
Hypertension
Antihypertensive Drugs and COVID-19 Risk: A Cohort Study of 2 Million Hypertensive Patients
★ 3
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
Hypertension
Semenzato L, Botton J, Drouin J, Baricault B, Vabre C, Cuenot F, Penso L, Herlemont P, Sbidian E, Weill A, Dray-Spira R, Zureik M
doi: 10.1161/HYPERTENSIONAHA.120.16314
Hypertension
Age and Multimorbidity Predict Death Among COVID-19 Patients: Results of the SARS-RAS Study of the Italian Society of Hypertension
Hypertension.
Iaccarino G, Grassi G, Borghi C, Ferri C, Salvetti M, Volpe M, SARS-RAS Investigator.
doi: 10.1161/HYPERTENSIONAHA.120.15324.
Hypertension
Association of Renin-Angiotensin System Inhibitors With Severity or Risk of Death in Patients With Hypertension Hospitalized for Coronavirus Disease 2019 (COVID-19) Infection in Wuhan, China
JAMA Cardiol.
Li J, Wang X, Chen J, Zhang H, Deng A
doi: 10.1001/jamacardio.
Hypertension
Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study
Eur Heart J.
Gao C, Cai Y, Zhang K, Zhou L, Zhang Y, Zhang X, Li Q, Li W, Yang S, Zhao X, Zhao Y, Wang H, Liu Y, Yin Z, Zhang R, Wang R, Yang M, Hui C, Wijns W, McEvoy JW, Soliman O, Onuma Y, Serruys PW, Tao L, Li F
doi: 10.1093/eurheartj/ehaa433.
Hypertension
Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people
Heart.
Hippisley-Cox J, Young D, Coupland C, Channon KM, Tan PS, Harrison DA, Rowan K, Aveyard P, Pavord ID, Watkinson PJ
doi: 10.1136/heartjnl-2020-317393.
Hypertension
Decreased Mortality of COVID-19 with Renin-Angiotensin-Aldosterone System Inhibitors Therapy in Patients with Hypertension: A Meta-Analysis
Hypertension.
Guo X, Zhu Y, Hong Y
doi: 10.
Hypertension
Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers Use and COVID-19 Infection Among 824,650 Patients with Hypertension from a US integrated Healthcare System
J Am Heart Assoc
An J, Wei R, Zhou H, Luong TQ, Gould MK, Mefford MT, Harrison TN, Creekmur B, Lee MS, Sim JJ, Brettler JW, Martin JP, Ong-Su AL, Reynolds K
doi: 10.1161/JAHA.120.019669
Further Publications
Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19)
JAMA Cardiol.
Mercuro NJ, Yen CF, Shim DJ, Maher TR, McCoy CM, Zimetbaum PJ, Gold HS
doi: 10.1001/jamacardio.
Hypertension
Mortality and Pre-Hospitalization use of Renin-Angiotensin System Inhibitors in Hypertensive COVID-19 Patients
J Am Heart Assoc.
Chen C, Wang F, Chen P, Jiang J, Cui G, Zhou N, Moroni F, Moslehi JJ, Ammirati E, Wang DW
doi: 10.1161/JAHA.120.017736.